0001315406-14-000092.txt : 20141114 0001315406-14-000092.hdr.sgml : 20141114 20141114164729 ACCESSION NUMBER: 0001315406-14-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141113 FILED AS OF DATE: 20141114 DATE AS OF CHANGE: 20141114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUTTON RONALD W CENTRAL INDEX KEY: 0001248073 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 141225028 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-11-13 0000012208 BIO RAD LABORATORIES INC BIO, BIOB 0001248073 HUTTON RONALD W C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 Vice President and Treasurer Bio-Rad A Common Stock 2014-11-13 4 M 0 1000 57.49 A 3496.7 D Bio-Rad A Common Stock 2014-11-13 4 M 0 1500 62.47 A 4996.7 D Bio-Rad A Common Stock 2014-11-13 4 S 0 1261 111.92 D 3735.7 D Bio-Rad A Common Stock 2014-11-13 4 S 0 1805 111.41 D 1930.7 D Non-Qualified Stock Option (right to buy) 57.49 2014-11-13 4 M 0 1000 0 D 2015-02-09 Bio-Rad A Common Stock 1000 0 D Non-Qualified Stock Option (right to buy) 62.47 2014-11-13 4 M 0 1500 0 D 2016-04-03 Bio-Rad A Common Stock 1500 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.89 to $111.94, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.39 to $111.43, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in five equal annual installments beginning on February 9, 2006. The option vested in five equal annual installments beginning on April 3, 2007. Ronald W. Hutton 2014-11-14